OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
OPTR was delisted on the 23rd of October, 2013.
104 hedge funds and large institutions have $526M invested in OPTIMER PHARMACEUTICALS, INC. COM STK in 2013 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 34 increasing their positions, 25 reducing their positions, and 33 closing their positions.
36% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 25
9% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 33
1% more funds holding
Funds holding: 103 → 104 (+1)
18% less capital invested
Capital invested by funds: $642M → $526M (-$116M)
74% less call options, than puts
Call options by funds: $1.84M | Put options by funds: $6.99M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WIC
Water Island Capital
New York
|
+$38.6M |
| 2 |
AAA
Alpine Associates Advisors
Englewood Cliffs,
New Jersey
|
+$29.3M |
| 3 |
DKCM
Davidson Kempner Capital Management
New York
|
+$24.4M |
| 4 |
JG
Jefferies Group
New York
|
+$21.2M |
| 5 |
Morgan Stanley
New York
|
+$19.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$44.7M |
| 2 |
DM
Deerfield Management
New York
|
-$43.8M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$38.1M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$35.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$27.9M |
OPTR Hedge Fund Activity: Q3 2013 in Review
104 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) for Q3 2013, worth a combined $526M — down 18% from $642M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new OPTR positions and 33 closed out — a net gain of 3 holders — while 34 added to existing stakes and 25 trimmed.
The largest buyer was Water Island Capital, adding an estimated $38.6M. The largest seller was Wellington Management Group, cutting an estimated $44.7M.
- 104 institutional investors held OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) as of Q3 2013, up from 103 in Q2 2013.
- Funds reported $526M of OPTIMER PHARMACEUTICALS, INC. COM STK stock for Q3 2013, down 18% quarter-over-quarter.
- 36 funds opened new OPTIMER PHARMACEUTICALS, INC. COM STK positions in Q3 2013 and 33 closed out, a net change of +3 holders.
- The largest OPTIMER PHARMACEUTICALS, INC. COM STK buyer in Q3 2013 was Water Island Capital, an estimated $38.6M added.
- The largest OPTIMER PHARMACEUTICALS, INC. COM STK seller in Q3 2013 was Wellington Management Group, an estimated $44.7M sold.
Based on aggregated 13F filings for Q3 2013.